Basic Principles III Flashcards
1
Q
70 kg person
A
- 3 L in plasma
- 9L in interstitial space
- 28 L intracellular
- Vd is volume drug should go in- so if it diffuses only in plasma- 3L, plasma and interstitial- 12L, and total is 40 L
2
Q
volume of distribution
A
- important pharmacokinetic parameter
- can be experimentally determined
- Vd= dose/cp (cp=dose/vd)
- administration of a drug causes a certain plasma concentration
- cp 1/alpha to vd
- cp increases, Vd decreases
- cp decreases, Vd increases ( can diffuse to more volume)
3
Q
vd
A
- L/kg
- doses in average adults are estimated in volunteer trials
- weights for kids used for dosing
- body surface area used in chemo
4
Q
apparent volume
A
- drug can get trapped by plasma volume- vd should be 12 but is only 3
- high degree of tissue binding creates a reservoir- should only be 28 but is over 40
- might need to give stimulus dose
5
Q
distribution
A
- vi is plasma- dynamic flux
- admin and elimination to and from Vi
- Vi also in flux with Vt- total Vd
- distribution into Vt and then back into Vi and leaves in elimination
- therefore two half lives- 1st into Vt, second for elimination
6
Q
factors affecting distribution
A
- blood flow- will distribute first to more vascular organs with higher blood flow
- ability of drug to enter a fluid space- pH, binding, transport, lipid solubility
- time after admin- equilibrium with various compartments may take a long time to achieve
- redistribution- drug may have to distribute from initial compartments to the target tissue
- size of the patient- Vd can vary with size- many drugs dosed on the basis of weight or body surface area, especially for Peds or chemo
7
Q
thiopental
A
- drug used for anesthesia
- goes to brain first and then redistributes to other organs
8
Q
placenta and distribution
A
- no barrier to drugs that are less than 1000 in molecular weight, which is most drugs
- fetal liver and kidney are immature
- PDR and other references
- safety ratings A-X
- B is humans ok, rats bad
- C is rat tested not human
- D is if abs needed
- X is teratogenic
9
Q
teratogenic effects
A
-esp in 1st trimester, abnormal tissue differentiation
10
Q
toxic effects
A
- may be chronic or acute
- chronic: addiction, birth weight, specific organ abnormalities
- acute: respiratory depression, hyperbilirubinemia, vascular problems
11
Q
blood brain barrier
A
- an anatomical protective barrier, created by the existence of tight junctions between the cap endo cells and choroid plexus cells in ventricles
- to enter CNS drug must be lipid soluble or transported by a carrier mediated mechanism
- have to give L dopa to get across and then get changed to dopamine
12
Q
caffeine example
A
LOOK IN NOTES FOR MATH
-get Vd into liters, then cp=dose/Vd
13
Q
consequences of barrier in brain
A
- can affect apparent drug potency
- may need to use lipid soluble precursors of the active drug
- will create special problems in treating overdoses of lipid soluble or electrolyte drugs
- may necessitate direct injection of certain drugs into the CNS
14
Q
weak acid drug in brain
A
- diffuses as HA then gets stuck in brain as A-
- must add bicarb to increase pH of plasma to draw acid back out
- use when overdose on aspirin or barbituates
15
Q
weak base drug and brain
A
- diffuses as RNH2 and gets stuck as RNH3+
- must increase acidity and decrease pH to cause PNH2 and H to combine outside the brain and draw more RNH2 out